Evidence map›Paper›PMID 38013679›Full record

ArticleCities & health2021

Pandemics, vulnerability, and prevention: time to fundamentally reassess how we value and communicate risk?: CITIES, HEALTH and COVID-19: Initial reflections and future challenges.

Daniel Black, Geoff Bates, Andy Gibson, Eli Hatleskog, Eleonora Fichera, Jenny Hatchard, Hasan Md Nazmul, Ges Rosenberg, Charles Larkin, Rachel Brierley and 11 more

Abstract read
In one paragraph

Article in Cities & health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Daniel BlackUniversity of Bristol, Bristol, UK.ORCID https://orcid.org/0000-0002-1474-6992
Geoff BatesUniversity of Bath, Bath, UK.
Andy GibsonUWE Bristol.
Eli HatleskogUniversity of Bristol, Bristol, UK.ORCID https://orcid.org/0000-0002-9265-9464
Eleonora FicheraUniversity of Bath, Bath, UK.
Jenny HatchardUniversity of Bristol, Bristol, UK.
Hasan Md NazmulUniversity of Bath, Bath, UK.
Ges RosenbergUniversity of Bristol, Bristol, UK.
Charles LarkinUniversity of Bath, Bath, UK.
Rachel BrierleyUniversity of Bristol, Bristol, UK.
Judi KidgerUniversity of Bristol, Bristol, UK.
Krista BondyUniversity of Bath, Bath, UK.
Matt HickmanUniversity of Bristol, Bristol, UK.
Kathy PainUniversity of Reading, Reading, UK.ORCID https://orcid.org/0000-0003-1451-9252
Ben HicksUniversity of Bristol, Bristol, UK.
Gabriel ScallyUniversity of Bristol, Bristol, UK.
Arpana VermaUniversity of Manchester, Manchester, UK.
Neil CarhartUniversity of Bristol, Bristol, UK.ORCID https://orcid.org/0000-0003-4503-7141
Alistair HuntUniversity of Bath, Bath, UK.
Paddy IrelandUniversity of Bristol, Bristol, UK.

Funding

Medical Research Council MR/S037586/1
6 · The paper itself

Abstract

For over a decade, pandemics have been on the UK National Risk Register as both the likeliest and most severe of threats. Non-infectious 'lifestyle' diseases were already crippling our healthcare services and our economy. COVID-19 has exposed two critical vulnerabilities: firstly, the UK's failure to adequately assess and communicate the severity of non-communicable disease; secondly, the health inequalities across our society, due not least to the poor quality of our urban environments. This suggests a potentially disastrous lack of preventative action and risk management more generally, notably with regards to the existential risks from the climate and ecological crises.

Indexed as

citiesinequalityNon-communicable diseaseprioritiesriskvulnerability

Identifiers

PMID38013679
PMCPMC10402659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.